1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
A combined cell and gene therapy approach for homotopic reconstruction of midbrain dopamine pathways using human pluripotent stem cells
(
- Contribution to journal › Article
- 2017
-
Mark
Toxic effects of human and rodent variants of alpha-synuclein in vivo
(
- Contribution to journal › Article
- 2013
-
Mark
Variability in Neuronal Expression of Dopamine Receptors and Transporters in the Substantia Nigra
(
- Contribution to journal › Article
-
Mark
Trophic factors differentiate dopamine neurons vulnerable to Parkinson's disease
(
- Contribution to journal › Article
-
Mark
LAMP2A as a therapeutic target in Parkinson disease
(
- Contribution to journal › Debate/Note/Editorial
- 2012
-
Mark
GIRK2 Expression in Dopamine Neurons of the Substantia Nigra and Ventral Tegmental Area
(
- Contribution to journal › Article
- 2010
-
Mark
The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson's disease
(
- Contribution to journal › Article
- 2001
-
Mark
Restorative and neuroprotective treatment strategies for Parkinson’s disease: tudies on fetal dopamine cell transplants and GDNF delivery by intracerebral injections and recombinant AAV vectors.
2001)(
- Thesis › Doctoral thesis (compilation)